Liquidia Corporation Common Stock vs Monolithic Power Systems Inc — how do they compare? Liquidia Corporation Common Stock trades at $33.46 (market cap $2.40B), while Monolithic Power Systems Inc trades at $1,227.85 (market cap $64.85B). The key difference: Monolithic Power Systems Inc is far larger — about 27× Liquidia Corporation Common Stock's market cap, and Monolithic Power Systems Inc pays a 0.61% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Monolithic Power Systems Inc for 25 Days on average.
| LQDA | MPWR | |
|---|---|---|
Market Cap | $2.40B | $64.85B |
Volume | 2,857,547 | 692,538 |
Sector | Health | Technology |
52-Week High | $91.03 | $1.69K |
52-Week Low | $22.02 | $856.96 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $2.30B | $63.45B |
Dividend Yield | — | 0.61% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MPWR trades at $1,319.55 with minimal daily movement (+0.02%) amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, 24.5% net margins, and robust revenue growth from $2.8B to $3.3B year-over-year. Recent news highlights CEO share sales and a manufacturing partnership with GlobalFoundries to support AI and data center demand. Valuation remains elevated with P/E at 80.5 and P/S at 19.7, reflecting high growth expectations.
The outlook remains positive given analyst consensus (88% buy ratings) and a $1,830 price target, but risks include premium valuation compression, insider selling, and dependence on AI infrastructure growth. Cash flow strength supports dividend payments, though technical weakness near key support at $1,300 requires monitoring for sustained bullish momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →